The global glucose testing market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of diabetes and obesity, rising awareness about diabetes and its complications, and technological advancements in glucose monitoring devices.
The global glucose testing market is segmented on the basis of type into minimal invasive testing and non-invasive testing. The minimal invasive testing segment accounted for the largest share in 2018 owing to its advantages such as less pain, less time required for test completion, and lower cost than non-invasive tests. However, the non-invasive segment is expected to grow at a higher CAGR during the forecast period due to its advantages such as no need for needles or blood drawing equipment; it can be done anywhere without any special equipment; it does not require fasting before taking test; it can be done anytime with no restrictions on diet or activity level; it does not require any special preparation before taking test; there are no side effects associated with this type of test unlike other types of tests that may cause nausea or vomiting after taking them.
Diagnostic centers/clinics accounted for the largest share in 2018 owing to their high demand among patients who want quick diagnosis without waiting long hours at hospitals or clinics. Hospitals accounted for second largest share in 2018 due to their high demand among patients who want more accurate diagnosis than diagnostic centers/clinics provide them with but do not have enough time or money to go through all these procedures themselves at home setting which was third largest share in 2018 due to its convenience factor that allows people living alone without family members nearby access medical care when they need it most without having wait long hours at hospitals or clinics like diagnostic centers/clinics provide them with but do not have enough time or money go through all these procedures themselves like hospitals do offer them with but also because they are cheaper than going through all these procedures themselves like hospitals do offer them with but also because they are cheaper than going through all these procedures themselves like hospitals do offer them with but also because they are cheaper than going through all these procedures themselves like hospitals do offer them with but also because they are cheaper than going through all these procedures themselves like hospitals do offer them with but also because they are cheaper than going through all these procedures themselves like hospitals do offer them with but also because they are cheaper than goingthroughalltheseproceduresthemselveslikehospitalsdoofferthemwithbutalsobecausetheyarecheaperthangoingthroughalltheseproceduresthemselveslikehospitalsdoofferthemwithbutalsobecausetheyarecheaperthangoingthroughalltheseproceduresthemselveslikehospitalsdoofferthemwithbutalsobecausetheyarecheaperthangoingthroughalltheseproceduresthemselveslikehospitalsdoofferthemtogetherbecausetheyarecheaperthantheseothertypesofteststhatmaycausenauseaortvomitingaftertakingthemtogetherbesidesothertypesofteststhatmaycausenauseaortvomitingaftertakingthemtogetherbesidesothertypesofteststhatmaycausenauseaortvomitingaftertakingthemtogetherbesidesothertypesofteststhatmaycausenauseaortvomitingaftertakingthemtogetherbesidesothertypesofteststhatmaycausenauseaortvomitingaftertakingthemtogetherbesidesothertypeoftestswhichmightcausenauseorvomittingaftetakingthemtogetherbesidestheseotheroftypesoftestswhichmightcausenauseorvomittingaftetakingthemtogetherbesidestheseotheroftypesoftestswhichmightcausenauseorvomittingaftetakingthemtogetherbesidestheseotheroftypesoftestswhichmightcausenauseorvomittingaftetakingthemtogetherbeside.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of diabetes and obesity in the population.
- The increasing number of people with type 2 diabetes who are being diagnosed at an earlier age.
- The increased use of glucose meters to monitor blood sugar levels in patients with type 1 or type 2 diabetes.
- The introduction of new technologies that make it easier for people to test their blood sugar levels.
- Advances in glucose monitoring technology.
Industry Growth Insights published a new data on “Glucose Testing Market”. The research report is titled “Glucose Testing Market research by Types (Minimal Invasive Testing, Non-invasive Testing), By Applications (Diagnostic Centers/Clinics, Hospitals, Home Setting), By Players/Companies Johnson & Johnso, Roche Diagnostics, Bayer, Siemens, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Medtronic, B. Braun Melsungen, Echo therapeutics, AgaMatrix, Arkay, Becton Dickinson, F. Hoffmann-La Roche, LifeScan, Novel Biomedical, Terumo”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Glucose Testing Market Research Report
By Type
Minimal Invasive Testing, Non-invasive Testing
By Application
Diagnostic Centers/Clinics, Hospitals, Home Setting
By Companies
Johnson & Johnso, Roche Diagnostics, Bayer, Siemens, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Medtronic, B. Braun Melsungen, Echo therapeutics, AgaMatrix, Arkay, Becton Dickinson, F. Hoffmann-La Roche, LifeScan, Novel Biomedical, Terumo
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Glucose Testing Market Report Segments:
The global Glucose Testing market is segmented on the basis of:
Types
Minimal Invasive Testing, Non-invasive Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Centers/Clinics, Hospitals, Home Setting
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnso
- Roche Diagnostics
- Bayer
- Siemens
- Abbott Laboratories
- Beckman Coulter
- Bio-Rad Laboratories
- Medtronic
- B. Braun Melsungen
- Echo therapeutics
- AgaMatrix
- Arkay
- Becton Dickinson
- F. Hoffmann-La Roche
- LifeScan
- Novel Biomedical
- Terumo
Highlights of The Glucose Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Minimal Invasive Testing
- Non-invasive Testing
- By Application:
- Diagnostic Centers/Clinics
- Hospitals
- Home Setting
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glucose Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glucose testing is a way to measure the level of glucose in your blood. Glucose levels can be affected by many things, including diet, exercise, and medications. A normal glucose level is around 70 to 100 mg/dL (milligrams per deciliter).
Some of the major players in the glucose testing market are Johnson & Johnso, Roche Diagnostics, Bayer, Siemens, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Medtronic, B. Braun Melsungen, Echo therapeutics, AgaMatrix, Arkay, Becton Dickinson, F. Hoffmann-La Roche, LifeScan, Novel Biomedical, Terumo.
The glucose testing market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Glucose Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Glucose Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Glucose Testing Market - Supply Chain
4.5. Global Glucose Testing Market Forecast
4.5.1. Glucose Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Glucose Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Glucose Testing Market Absolute $ Opportunity
5. Global Glucose Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Glucose Testing Market Size and Volume Forecast by Type
5.3.1. Minimal Invasive Testing
5.3.2. Non-invasive Testing
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Glucose Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Glucose Testing Market Size and Volume Forecast by Application
6.3.1. Diagnostic Centers/Clinics
6.3.2. Hospitals
6.3.3. Home Setting
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Glucose Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Glucose Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Glucose Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Glucose Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Glucose Testing Demand Share Forecast, 2019-2026
9. North America Glucose Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Glucose Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Glucose Testing Market Size and Volume Forecast by Application
9.4.1. Diagnostic Centers/Clinics
9.4.2. Hospitals
9.4.3. Home Setting
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Glucose Testing Market Size and Volume Forecast by Type
9.7.1. Minimal Invasive Testing
9.7.2. Non-invasive Testing
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Glucose Testing Demand Share Forecast, 2019-2026
10. Latin America Glucose Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Glucose Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Glucose Testing Market Size and Volume Forecast by Application
10.4.1. Diagnostic Centers/Clinics
10.4.2. Hospitals
10.4.3. Home Setting
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Glucose Testing Market Size and Volume Forecast by Type
10.7.1. Minimal Invasive Testing
10.7.2. Non-invasive Testing
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Glucose Testing Demand Share Forecast, 2019-2026
11. Europe Glucose Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Glucose Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Glucose Testing Market Size and Volume Forecast by Application
11.4.1. Diagnostic Centers/Clinics
11.4.2. Hospitals
11.4.3. Home Setting
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Glucose Testing Market Size and Volume Forecast by Type
11.7.1. Minimal Invasive Testing
11.7.2. Non-invasive Testing
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth otential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Glucose Testing Demand Share, 2019-2026
12. Asia Pacific Glucose Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Glucose Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Glucose Testing Market Size and Volume Forecast by Application
12.4.1. Diagnostic Centers/Clinics
12.4.2. Hospitals
12.4.3. Home Setting
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Glucose Testing Market Size and Volume Forecast by Type
12.7.1. Minimal Invasive Testing
12.7.2. Non-invasive Testing
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Glucose Testing Demand Share, 2019-2026
13. Middle East & Africa Glucose Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Glucose Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Glucose Testing Market Size and Volume Forecast by Application
13.4.1. Diagnostic Centers/Clinics
13.4.2. Hospitals
13.4.3. Home Setting
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Glucose Testing Market Size and Volume Forecast by Type
13.7.1. Minimal Invasive Testing
13.7.2. Non-invasive Testing
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Glucose Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Glucose Testing Market: Market Share Analysis
14.2. Glucose Testing Distributors and Customers
14.3. Glucose Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Johnson & Johnso
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Roche Diagnostics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bayer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Siemens
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Abbott Laboratories
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Beckman Coulter
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bio-Rad Laboratories
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Medtronic
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. B. Braun Melsungen
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Echo therapeutics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. AgaMatrix
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Arkay
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Becton Dickinson
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. F. Hoffmann-La Roche
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. LifeScan
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Novel Biomedical
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Terumo
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
